FDA-Drug2017-02-08Class II
MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- NDC 63323-412-05
Fresenius Kabi USA, LLC
Hazard
Failed Impurities/Degradation Specifications
Sold states
Nationwide and Puerto Rico
Affected count
47, 020 vials
Manufactured in
3 Corporate Dr, N/A, Lake Zurich, IL, United States
Products
MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- NDC 63323-412-05
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0456-2017Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief